U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06857370) titled 'Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined Vaccine' on Feb. 26.
Brief Summary: This is a randomized, blinded, peer-controlled study. There will be 3 treatment groups, screened subjects were randomized in a 1:1:1 ratio to receive three batches of the DTcP trial vaccine, and completed the primary immunization according to the procedure of one dose each at 2, 4, and 6 months of age.
Study Start Date: March 20
Study Type: INTERVENTIONAL
Condition:
Diphtheria, Tetanus and Acellular Pertussis
Intervention:
BIOLOGICAL: Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combin...